Literature DB >> 15630365

Sclerosing rhabdomyosarcoma: a rare variant with predilection for the head and neck.

Thomas A Knipe1, Rakesh K Chandra, M Frederick Bugg.   

Abstract

OBJECTIVES/HYPOTHESIS: Sclerosing rhabdomyosarcoma is a newly described variant of rhabdomyosarcoma with a predilection for the head and neck. Little has been written on the topic, because of the scarcity of the disease and its recent recognition as a distinct entity. The present report describes the fifth confirmed case of sclerosing rhabdomyosarcoma and is the first report in the otolaryngology literature. STUDY
DESIGN: Case report.
METHODS: The authors have reported the case of a 66-year-old woman with a 35-year history of heavy cigarette smoking and daily alcohol consumption and a 2-month history of progressive dysphagia and dysarthria secondary to an enlarging tongue mass. Urgent tracheotomy was performed for impending respiratory embarrassment. Direct laryngoscopy revealed a bulky, exophytic mass involving the base of tongue. Specimens were obtained and submitted for analysis.
RESULTS: Initial frozen-section analysis of the specimens favored carcinoma, although subsequent immunohistochemical analysis disproved this. The diagnosis of sclerosing rhabdomyosarcoma was based on microscopic appearance and patterns of gene expression, including the expression of desmin and myogenin. A search of the literature revealed only four confirmed cases of sclerosing rhabdomyosarcoma. With the inclusion of the oropharyngeal tumor in the present report, three of the five confirmed cases have occurred in the head and neck.
CONCLUSION: Sclerosing rhabdomyosarcoma is a rare variant of rhabdomyosarcoma that has a predilection for the head and neck. The clinical presentation may mimic carcinoma. The otolaryngologist-head and neck surgeon must be familiar with this disease entity.

Entities:  

Mesh:

Year:  2005        PMID: 15630365     DOI: 10.1097/01.mlg.0000150676.75978.3c

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  7 in total

1.  Sclerosing pseudovascular rhabdomyosarcoma-immunohistochemical, ultrastructural, and genetic findings indicating a distinct subtype of rhabdomyosarcoma.

Authors:  Cornelius Kuhnen; Peter Herter; Ivo Leuschner; Thomas Mentzel; Daniel Druecke; Malgorzata Jaworska; Georg Johnen
Journal:  Virchows Arch       Date:  2006-10-03       Impact factor: 4.064

Review 2.  Sclerosing rhabdomyosarcoma: report of a case arising in the head and neck of an adult and review of the literature.

Authors:  Julie C Robinson; Mary S Richardson; Brad W Neville; Terrence A Day; Angela C Chi
Journal:  Head Neck Pathol       Date:  2012-09-19

Review 3.  Sclerosing rhabdomyosarcoma: presentation of a rare sarcoma mimicking myoepithelial carcinoma of the parotid gland and review of the literature.

Authors:  Blake M Warner; Christopher C Griffith; William D Taylor; Raja R Seethala
Journal:  Head Neck Pathol       Date:  2014-04-08

4.  Testicular fusocellular rhabdomyosarcoma as a metastasis of elbow sclerosing rhabdomyosarcoma: A clinicopathologic, immunohistochemical and molecular study of one case.

Authors:  Miguel Martorell; Cristian M Ortiz; Jose Angel Garcia
Journal:  Diagn Pathol       Date:  2010-08-11       Impact factor: 2.644

5.  Spindle cell/sclerosing rhabdomyosarcoma with intracranial invasion without destroying the bone of the skull base: a case report and literature review.

Authors:  Daichi Momosaka; Osamu Togao; Akio Hiwatashi; Koji Yamashita; Koji Yoshimoto; Megumu Mori; Toru Iwaki; Hiroshi Honda
Journal:  Acta Radiol Open       Date:  2017-08-18

6.  MDM2 Amplification and PI3KCA Mutation in a Case of Sclerosing Rhabdomyosarcoma.

Authors:  Ken Kikuchi; George R Wettach; Christopher W Ryan; Arthur Hung; Jody E Hooper; Carol Beadling; Andrea Warrick; Christopher L Corless; Susan B Olson; Charles Keller; Atiya Mansoor
Journal:  Sarcoma       Date:  2013-05-20

7.  Sclerosing rhabdomyosarcoma presenting in the masseter muscle: a case report.

Authors:  Xu-Yong Lin; Yan Wang; Juan-Han Yu; Yang Liu; Liang Wang; Qing-Chang Li; En-Hua Wang
Journal:  Diagn Pathol       Date:  2013-02-04       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.